STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Revenue growth
-93.0%
XBRL, annual
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$278.3K
four quarters, 2025-08-01 to 2026-07-31
History
FY Oct 2025
$484.7K
FY Oct 2024
$6.9M
FY Oct 2023
$13.1M
FY Oct 2022
$12.8M
FY Oct 2021
$58.8M
Jul 2026
$55.3K
Apr 2026
$37.5K
Jan 2026
$92.9K
Oct 2025
$92.6K
Jul 2025
$142.4K
Apr 2025
$47.0K
Jan 2025
$202.6K
Oct 2024
$735.0K
At each fiscal year end
Single quarter
Net margin, TTM
n/a
revenue under $1M, the ratio says nothing
History
FY Oct 2025
n/a
FY Oct 2024
-97.3%
FY Oct 2023
-85.1%
FY Oct 2022
-112.6%
FY Oct 2021
-15.4%
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
-202.3%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$2.1M
operating cash flow minus capex, 2025-08-01 to 2026-07-31
History
FY Oct 2025
-$2.8M
FY Oct 2024
-$672.6K
FY Oct 2023
-$3.0M
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
History
FY Oct 2025
n/a
FY Oct 2024
n/a
FY Oct 2023
n/a
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
History
FY Oct 2025
n/a
FY Oct 2024
n/a
FY Oct 2023
n/a
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-232.7%
TTM net income over average of 2025-07-31 and 2026-07-31
History
FY Oct 2025
-239.0%
FY Oct 2024
-48.9%
FY Oct 2023
-95.3%
FY Oct 2022
-110.0%
FY Oct 2021
-87.1%
Jul 2026
-232.7%
Apr 2026
-221.6%
Jan 2026
-200.8%
Oct 2025
-239.0%
Jul 2025
-68.6%
Apr 2025
-88.9%
Jan 2025
-70.9%
Oct 2024
-48.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-194.1%
TTM net income over average of 2025-07-31 and 2026-07-31
History
FY Oct 2025
-199.5%
FY Oct 2024
-37.9%
FY Oct 2023
-70.0%
FY Oct 2022
-67.4%
FY Oct 2021
-46.2%
Jul 2026
-194.1%
Apr 2026
-186.0%
Jan 2026
-175.8%
Oct 2025
-199.5%
Jul 2025
-55.8%
Apr 2025
-69.8%
Jan 2025
-57.0%
Oct 2024
-37.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
History
FY Oct 2025
n/a
FY Oct 2024
n/a
FY Oct 2023
n/a
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
History
FY Oct 2025
n/a
FY Oct 2024
n/a
FY Oct 2023
n/a
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
History
FY Oct 2025
n/a
FY Oct 2024
n/a
FY Oct 2023
n/a
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
History
FY Oct 2025
n/a
FY Oct 2024
n/a
FY Oct 2023
n/a
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-378.2%
TTM free cash flow over market value at close 2026-10-09
History
FY Oct 2025
-41.7%
FY Oct 2024
-9.9%
FY Oct 2023
-0.8%
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
-423.6%
Apr 2026
-586.4%
Jan 2026
-1,075%
Oct 2025
-41.7%
Jul 2025
-50.5%
Apr 2025
-52.5%
Jan 2025
-18.8%
Oct 2024
-9.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
History
FY Oct 2025
n/a
FY Oct 2024
n/a
FY Oct 2023
n/a
FY Oct 2022
n/a
FY Oct 2021
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-09. Hover a figure to see how it was computed.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
KAVL ranks highest on risk and compliance (81st percentile) and profitability (5th), and lowest on growth (1st), among Wholesale & Retail peers.
Profitability
5
Inputs
Return on equity-232.7% · 4 pct, sector of 207
Return on assets-194.1% · 6 pct, sector of 259
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Growth
1
Inputs
Revenue growth, YoY-93.0% · 1 pct, sector of 313
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
81
Inputs
Short interest, % of float+0.1% · 89 pct, sector of 321
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-K+6.8% · 73 pct, sector of 226
4 not measured: Financial health, Insider conviction, Institutional and government, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no insider trades in 180 days; no open-market insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for Kaival Brands Innovations Group, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-12.
No password to create and no card required. We store your email address and nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in. Google Analytics and
Microsoft Clarity load only if you allow them here, to show us which datasets matter.
No ad trackers, ever. Details in the privacy
policy.